Fig. 3From: Evaluation of a 55-gene classifier as a prognostic biomarker for adjuvant chemotherapy in stage III colon cancer patientsFive-year relapse-free survival (RFS) curves of patients treated with [I-OHP(+), indicated in red] and without oxaliplatin [I-OHP(−), indicated in blue] according to the 55-gene classifier (55GC) subtypes [top: microsatellite instability (MSI)-like; middle: chromosomal instability (CIN)-like; bottom: stromal]Back to article page